Hubei Biocause Heilen Pharmaceutical Co., Ltd is a prominent manufacturer in the pharmaceutical industry, specialising in the production of Active Pharmaceutical Ingredients (APIs). The company operates with a strong focus on quality and compliance, boasting two API production sites and a dedicated R&D centre. Hubei Biocause has been inspected and approved by the US FDA on seven occasions and the EU GMP four times. With a diverse product portfolio that includes Abiraterone Acetate, Ibuprofen, Milrinone, Fludarabine, Granisetron, and Flumazenil, the company exports to over 85 countries globally, with significant sales into highly regulated markets such as the USA and EU.

Services include:
- APIs (Active Pharmaceutical Ingredients)
- Contract Development and Manufacturing (CDMO)
- Regulatory Services
- Containment
- Solid Dosage

Hubei Biocause Heilen Pharmaceutical Co., Ltd is committed to delivering high-quality pharmaceutical solutions and regulatory compliance, ensuring a robust supply chain for its partners. For more information, visit biocause.com.